CABALETTA BIO, INC. Capital Expenditures Incurred but Not yet Paid
CABALETTA BIO, INC. (CABA) reported Capital Expenditures Incurred but Not yet Paid of $265.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-13
- CABALETTA BIO, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- CABALETTA BIO, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$43.00K, a 637.50% decline year-over-year.
- CABALETTA BIO, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $43.00K.
- CABALETTA BIO, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CABALETTA BIO, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CABALETTA BIO, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $404.00K, a 42.45% decline from fiscal 2023.
- CABALETTA BIO, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $702.00K.
- CABALETTA BIO, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $265.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$43.00K derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-03-23 |
| 2025-09-30 | -$43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-10 | $21.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $43.00K 10-Q · filed 2026-08-13 | $64.00K derived: sum of 3 quarters · filed 2026-08-13 | $72.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | $21.00K derived: sum of 2 quarters · filed 2026-03-23 | $29.00K derived: sum of 3 quarters · filed 2026-03-23 | -$258.00K derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $29.00K derived: sum of 2 quarters · filed 2026-03-23 | -$258.00K derived: sum of 3 quarters · filed 2026-03-23 | $404.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$279.00K derived: sum of 2 quarters · filed 2025-11-10 | $383.00K 10-Q · filed 2025-11-10 | $1.08M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $375.00K 10-Q · filed 2025-08-07 | $1.08M derived: sum of 3 quarters · filed 2025-08-07 | $1.05M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $662.00K 10-Q · filed 2025-05-15 | $1.36M derived: sum of 2 quarters · filed 2025-05-15 | $1.34M derived: sum of 3 quarters · filed 2025-05-15 | $1.36M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $679.00K derived: sum of 2 quarters · filed 2025-03-31 | $702.00K derived: sum of 3 quarters · filed 2025-03-31 | $702.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | -$191.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $23.00K 10-Q · filed 2024-08-08 | -$168.00K derived: sum of 3 quarters · filed 2024-08-08 | -$393.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | -$191.00K derived: sum of 2 quarters · filed 2024-05-15 | -$416.00K derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$416.00K derived: sum of 2 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 | |
| 2022-09-30 | -$225.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $191.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $416.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$385.00K derived: sum of 2 quarters · filed 2023-03-16 | -$241.00K derived: sum of 3 quarters · filed 2023-03-16 | $135.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$300.00K derived: sum of 2 quarters · filed 2022-11-10 | $76.00K 10-Q · filed 2022-11-10 | -$131.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $520.00K 10-Q · filed 2022-08-11 | $313.00K derived: sum of 3 quarters · filed 2022-08-11 | $414.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $376.00K 10-Q · filed 2022-05-12 | $169.00K derived: sum of 2 quarters · filed 2022-05-12 | $270.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$106.00K derived: sum of 2 quarters · filed 2022-03-17 | $20.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $227.00K 10-Q · filed 2021-11-01 | ||
| 2020-06-30 | $126.00K 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $226.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $174.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |